TerrAscend Awaits Health Canada Approval for Cannabis Sales

Visit the TerrAscend Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

TerrAscend Corp provides update on sales licence application

TORONTO, March 9, 2018 /CNW/ – At the request of IIROC and as a result of the recent increase in market activity, TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is providing an update on its sales licence application. Solace Health Inc. (“Solace”), a wholly-owned subsidiary of TerrAscend, has completed the final stages of its application for a sales licence that would permit it to sell dried cannabis from its production facility located in Mississauga, Ontario. Solace has responded to all of Health Canada’s requests to date and is waiting for final approval.

About TerrAscend

TerrAscend is a Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of consumers. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licenced producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Terra Health Network Inc., a clinical support program and education platform led by healthcare professionals.

Please visit www.TerrAscend.com for more information about the Company.

Original Press Release

The most reliable, fact-based information on TerrAscend found only on its Investor Dashboard.

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.

Get Our Sunday Newsletter